Form 4 Filing for Cellectar Biosciences, Inc. - Officer Stock Option Grant

This filing details a Form 4 submission by Cellectar Biosciences, Inc. concerning a stock option grant to Jarrod Longcor, the Chief Operating Officer. The grant, consisting of 118,000 stock options for common stock, was contingently awarded on May 28, 2026, and officially granted on July 7, 2026, following stockholder approval of the amended 2021 Stock Incentive Plan. The options have an exercise price of $3.14 and will vest over three years starting May 28, 2026. The option expires on May 28, 2036. Mr. Longcor acquired these options directly. The filing also notes that the options were granted with a transaction price of $0.00, and Mr. Longcor will own 118,000 shares after this transaction.